Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (141-150 of 587) with videos related to

Pageof 59
Sort By:
Journal of Neural Transmission. Supplementum|August 30, 2003
Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's diseaseM Gerlach, K Double, H Reichmann, et al.
Journal of Neural Transmission. Supplementum|January 1, 1992
Neurotoxicity and neuroprotection in Parkinson's diseaseK W Lange, M B Youdim, P Riederer
Clinical Pharmacology and Therapeutics|December 1, 1994
Biochemical actions of l-deprenyl (selegiline)K W Lange, P Riederer, M B Youdim
Journal of Neural Transmission|January 1, 1983
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizzinessW Birkmayer, G Birkmayer, H Lechner, et al.
Journal of Neural Transmission|January 1, 1984
L-deprenyl plus L-phenylalanine in the treatment of depressionW Birkmayer, P Riederer, W Linauer, et al.
Deutsche Medizinische Wochenschrift (1946)|May 17, 1974
[Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)]L Ambrozi, P Riederer, W Birkmayer, et al.
Biological Psychiatry|February 1, 1992
3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspectsN Wodarz, J Fritze, J Kornhuber, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
Amantadine and memantine are NMDA receptor antagonists with neuroprotective propertiesJ Kornhuber, M Weller, K Schoppmeyer, et al.
European Journal of Pharmacology|May 11, 1989
Isoelectric focusing of monoamine oxidase subtypes as identified by MAO inhibitorsJ Fritze, P Koronakis, C Konradi, et al.
Psychopathology|January 1, 1987
Biochemical aspects of dysphoria: case study for hypothesis generationP Kruzik, E Sofic, P Riederer, et al.
Pageof 59

Showing results (141-150 of 587) with videos related to

Sort By:
Pageof 59
Journal of Neural Transmission. Supplementum|August 30, 2003
Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's diseaseM Gerlach, K Double, H Reichmann, et al.
Journal of Neural Transmission. Supplementum|January 1, 1992
Neurotoxicity and neuroprotection in Parkinson's diseaseK W Lange, M B Youdim, P Riederer
Clinical Pharmacology and Therapeutics|December 1, 1994
Biochemical actions of l-deprenyl (selegiline)K W Lange, P Riederer, M B Youdim
Journal of Neural Transmission|January 1, 1983
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizzinessW Birkmayer, G Birkmayer, H Lechner, et al.
Journal of Neural Transmission|January 1, 1984
L-deprenyl plus L-phenylalanine in the treatment of depressionW Birkmayer, P Riederer, W Linauer, et al.
Deutsche Medizinische Wochenschrift (1946)|May 17, 1974
[Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)]L Ambrozi, P Riederer, W Birkmayer, et al.
Biological Psychiatry|February 1, 1992
3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspectsN Wodarz, J Fritze, J Kornhuber, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
Amantadine and memantine are NMDA receptor antagonists with neuroprotective propertiesJ Kornhuber, M Weller, K Schoppmeyer, et al.
European Journal of Pharmacology|May 11, 1989
Isoelectric focusing of monoamine oxidase subtypes as identified by MAO inhibitorsJ Fritze, P Koronakis, C Konradi, et al.
Psychopathology|January 1, 1987
Biochemical aspects of dysphoria: case study for hypothesis generationP Kruzik, E Sofic, P Riederer, et al.
Pageof 59